Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study

Gene Therapy
S-H YangY-C Sung

Abstract

Despite recent advances in the chemotherapy of chronic hepatitis B (CHB), an effective viral suppression after cessation of therapy has not yet been achieved. To investigate whether hepatitis B virus (HBV)-specific T-cell responses are inducible and can contribute to the viral suppression after cessation of the therapy, we conducted a proof-of-concept study with a DNA vaccine comprising of most HBV genes plus genetically engineered interleukin-12 DNA (IL-12N222L) in 12 CHB carriers being treated with lamivudine (LAM). When the ex vivo and/or cultured IFN-gamma enzyme-linked immunospot (ELISPOT) assay was performed, the detectable HBV-specific IFN-gamma secreting T-cell responses were observed at the end of treatment and during a follow-up. These type 1T-cell responses, particularly CD4(+) memory T-cell responses could be maintained for at least 40 weeks after the therapy and correlated with virological responses, but not with alanine aminotransferase elevation. Moreover, DNA vaccination under LAM treatment appeared to be well-tolerated and showed 50% of virological response rate in CHB carriers. Thus, a combination therapy of the DNA vaccine with chemotherapy may be one of new immunotherapeutic methods for the cure of CHB.

References

Jan 1, 1995·Annual Review of Immunology·F V Chisari, C Ferrari
Apr 1, 1996·The Journal of Clinical Investigation·B RehermannF V Chisari
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·M A NowakH McDade
Oct 29, 1996·Proceedings of the National Academy of Sciences of the United States of America·M ManciniM L Michel
Apr 1, 1997·Journal of Virology·V J CavanaughF V Chisari
Jul 9, 1998·The New England Journal of Medicine·C L LaiD F Gray
Oct 21, 1999·The New England Journal of Medicine·J L DienstagN A Brown
Feb 15, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P PancholiA M Prince
Apr 3, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C BoniC Ferrari
May 29, 2001·Gastroenterology·A S LokJ H Hoofnagle
Oct 5, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S J Hadziyannis, D Vassilopoulos
Oct 10, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·K L FlanaganM Plebanski
Aug 8, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Andrew J GodkinPeter J Openshaw
Sep 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jae Kwang YooYoung Chul Sung
Feb 4, 2003·Nature Immunology·E John WherryRafi Ahmed
Feb 28, 2003·The New England Journal of Medicine·Stephanos J HadziyannisUNKNOWN Adefovir Dipivoxil 438 Study Group
Feb 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jun ChangYoung-Chul Sung
Sep 24, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Maryline Mancini-BourgineMarie-Louise Michel
Dec 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jenni M VuolaAdrian V S Hill
Oct 27, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Eirini I RigopoulouNikolai V Naoumov

❮ Previous
Next ❯

Citations

Apr 12, 2007·Archives of Pharmacal Research·Eun Sung KangByong Moon Kim
Dec 12, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sunyoung KimYasufumi Kaneda
Mar 24, 2010·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Tanju B OzkanSibel Aker
Apr 12, 2012·World Journal of Gastroenterology : WJG·Jian-Hua ChenZheng-Hao Tang
Jan 1, 2009·Experimental & Molecular Medicine·Chae Young KimByung Gee Kim
Dec 23, 2011·Gastroenterology Research and Practice·Yasuteru KondoTooru Shimosegawa
Oct 14, 2014·Future Virology·Rama Kapoor, Shyam Kottilil
Dec 29, 2010·Hepatitis Research and Treatment·Anna D KosinskaMichael Roggendorf
Apr 1, 2009·Clinical Journal of Gastroenterology·Yasuteru KondoTooru Shimosegawa
May 27, 2016·Jundishapur Journal of Microbiology·Mohammad-Hassan PouriayevaliFarzaneh Sabahi
Feb 26, 2009·International Reviews of Immunology·Genevieve InchauspeJean Yves Bonnefoy
Oct 13, 2009·Expert Review of Gastroenterology & Hepatology·Antonio Bertoletti, Adam Gehring
Dec 22, 2006·Expert Review of Vaccines·Stanislas Pol, Marie-Louise Michel
Dec 3, 2015·Expert Review of Gastroenterology & Hepatology·Sheikh Mohammad Fazle AkbarYoichi Hiasa
Feb 9, 2012·Expert Review of Vaccines·Fadi Saade, Nikolai Petrovsky
Dec 21, 2012·Expert Review of Vaccines·Fadi SaadeNikolai Petrovsky
May 11, 2013·Expert Review of Vaccines·Daniel O VillarrealDavid B Weiner
Jan 17, 2007·Expert Opinion on Biological Therapy·Gloria Gonzalez-AseguinolazaAstrid Paneda
Jan 23, 2016·The Lancet Infectious Diseases·Mayur BrahmaniaHarry L A Janssen
Aug 5, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T Jake LiangAnna S Lok
Dec 29, 2015·Expert Review of Vaccines·Lei Li, Nikolai Petrovsky
Apr 13, 2010·Pathologie-biologie·M-L Michel, P Tiollais
Jun 30, 2009·Gastroentérologie Clinique Et Biologique·C Trépo, F Zoulim
Nov 21, 2007·Journal of Viral Hepatitis·G Inchauspé, M L Michel
Mar 15, 2016·Immunotherapy·Forough Golsaz-Shirazi, Fazel Shokri
Oct 1, 2011·Microbial Biotechnology·Sarah KutscherUlrike Protzer
Mar 14, 2014·Liver International : Official Journal of the International Association for the Study of the Liver·Seung Kew YoonYoung Chul Sung
Dec 10, 2013·Clinical & Developmental Immunology·Sandra A Calarota, Fausto Baldanti
Jan 18, 2011·Journal of Hepatology·Marie-Louise MichelMaryline Mancini-Bourgine
Apr 19, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Buddhadev LayekJagdish Singh
Dec 17, 2014·Medical Microbiology and Immunology·Marie-Louise MichelStanislas Pol

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.